Pfizer
NEWS
After two of Allergan’s investors, Appaloosa Management and Senator Investment Group, wrote to the company’s board asking that Brent Saunders’ duties be split up, legendary investor Carl Icahn appears to be building a position in the company—again.
The Biocom Institute and California Life Sciences Institute (CLSI) released their third biennial life science industry report. Overall, the report paints a very positive picture of the life science industry in California.
One of the hot topics at this year’s BIO International Convention being held in Boston is “patient-centricity.”
Actor, director and advocate Rob Reiner opened the third day of the 2018 BIO International Convention.
Metracrine, based in San Diego, completed a Series C financing round worth $65 million.
Pfizer is now throwing an additional $600 million into its venture capital fund, with a quarter of it earmarked for neuroscience research investments.
BioSpace takes a look at some notable programs that have been shuttered so far this year.
The 2018 BIO International Convention will be officially running from June 4 through June 7 and is celebrating 25 years of innovation.
With the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting ongoing, there are hundreds of newsworthy stories. Here is a few of our top picks so far.
JOBS
IN THE PRESS